Cargando…
Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms
INTRODUCTION: For many tumors, the overexpression of the chemokine receptor CXCR4 is associated with increased malignancy and poor patient outcomes. However, comprehensive data for neuroendocrine neoplasms of the lung are still lacking. METHODS: CXCR4 expression was evaluated in a panel of bronchopu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413658/ https://www.ncbi.nlm.nih.gov/pubmed/25671300 |
_version_ | 1782368817133912064 |
---|---|
author | Kaemmerer, Daniel Reimann, Christiane Specht, Elisa Wirtz, Ralph M. Sayeg, Manal Baum, Richard P. Schulz, Stefan Lupp, Amelie |
author_facet | Kaemmerer, Daniel Reimann, Christiane Specht, Elisa Wirtz, Ralph M. Sayeg, Manal Baum, Richard P. Schulz, Stefan Lupp, Amelie |
author_sort | Kaemmerer, Daniel |
collection | PubMed |
description | INTRODUCTION: For many tumors, the overexpression of the chemokine receptor CXCR4 is associated with increased malignancy and poor patient outcomes. However, comprehensive data for neuroendocrine neoplasms of the lung are still lacking. METHODS: CXCR4 expression was evaluated in a panel of bronchopulmonary neuroendocrine neoplasms (BP-NEN) comprising typical carcinoids (n = 26), atypical carcinoids (n = 30), and small cell lung cancers (SCLC, n = 34). Samples were analyzed by immunohistochemistry using the novel monoclonal rabbit anti-human CXCR4 antibody UMB-2 and by qRT-PCR. The expression was correlated with clinical data and overall patient survival. RESULTS: CXCR4 was predominantly localized at the plasma membrane of the tumor cells. CXCR4 was expressed with a high intensity in almost all of the 30 SCLC samples. In contrast, it was detected infrequently and with low intensity in the typical carcinoid and atypical carcinoid samples. There was a significant correlation between the immunohistochemistry and qRT-PCR data. Additionally, there was a significant negative relationship between CXCR4 expression and overall survival. CONCLUSIONS: With increasing malignancy, BP-NEN clearly differ in the extent of CXCR4 expression. As in other tumor entities, CXCR4 overexpression significantly correlates with negative patient outcome. Due to its particular high expression rate in SCLC, CXCR4 may serve as a promising new target for diagnostic and pharmacological intervention as well as for peptide receptor-based radionuclide therapy. |
format | Online Article Text |
id | pubmed-4413658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-44136582015-05-08 Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms Kaemmerer, Daniel Reimann, Christiane Specht, Elisa Wirtz, Ralph M. Sayeg, Manal Baum, Richard P. Schulz, Stefan Lupp, Amelie Oncotarget Research Paper INTRODUCTION: For many tumors, the overexpression of the chemokine receptor CXCR4 is associated with increased malignancy and poor patient outcomes. However, comprehensive data for neuroendocrine neoplasms of the lung are still lacking. METHODS: CXCR4 expression was evaluated in a panel of bronchopulmonary neuroendocrine neoplasms (BP-NEN) comprising typical carcinoids (n = 26), atypical carcinoids (n = 30), and small cell lung cancers (SCLC, n = 34). Samples were analyzed by immunohistochemistry using the novel monoclonal rabbit anti-human CXCR4 antibody UMB-2 and by qRT-PCR. The expression was correlated with clinical data and overall patient survival. RESULTS: CXCR4 was predominantly localized at the plasma membrane of the tumor cells. CXCR4 was expressed with a high intensity in almost all of the 30 SCLC samples. In contrast, it was detected infrequently and with low intensity in the typical carcinoid and atypical carcinoid samples. There was a significant correlation between the immunohistochemistry and qRT-PCR data. Additionally, there was a significant negative relationship between CXCR4 expression and overall survival. CONCLUSIONS: With increasing malignancy, BP-NEN clearly differ in the extent of CXCR4 expression. As in other tumor entities, CXCR4 overexpression significantly correlates with negative patient outcome. Due to its particular high expression rate in SCLC, CXCR4 may serve as a promising new target for diagnostic and pharmacological intervention as well as for peptide receptor-based radionuclide therapy. Impact Journals LLC 2014-12-30 /pmc/articles/PMC4413658/ /pubmed/25671300 Text en Copyright: © 2015 Kaemmerer et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Kaemmerer, Daniel Reimann, Christiane Specht, Elisa Wirtz, Ralph M. Sayeg, Manal Baum, Richard P. Schulz, Stefan Lupp, Amelie Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms |
title | Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms |
title_full | Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms |
title_fullStr | Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms |
title_full_unstemmed | Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms |
title_short | Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms |
title_sort | differential expression and prognostic value of the chemokine receptor cxcr4 in bronchopulmonary neuroendocrine neoplasms |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413658/ https://www.ncbi.nlm.nih.gov/pubmed/25671300 |
work_keys_str_mv | AT kaemmererdaniel differentialexpressionandprognosticvalueofthechemokinereceptorcxcr4inbronchopulmonaryneuroendocrineneoplasms AT reimannchristiane differentialexpressionandprognosticvalueofthechemokinereceptorcxcr4inbronchopulmonaryneuroendocrineneoplasms AT spechtelisa differentialexpressionandprognosticvalueofthechemokinereceptorcxcr4inbronchopulmonaryneuroendocrineneoplasms AT wirtzralphm differentialexpressionandprognosticvalueofthechemokinereceptorcxcr4inbronchopulmonaryneuroendocrineneoplasms AT sayegmanal differentialexpressionandprognosticvalueofthechemokinereceptorcxcr4inbronchopulmonaryneuroendocrineneoplasms AT baumrichardp differentialexpressionandprognosticvalueofthechemokinereceptorcxcr4inbronchopulmonaryneuroendocrineneoplasms AT schulzstefan differentialexpressionandprognosticvalueofthechemokinereceptorcxcr4inbronchopulmonaryneuroendocrineneoplasms AT luppamelie differentialexpressionandprognosticvalueofthechemokinereceptorcxcr4inbronchopulmonaryneuroendocrineneoplasms |